Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, OK
The Flex-V Study
We’re hoping to discover something…..the real you
We are conducting a clinical research study to test the safety and effectiveness of an investigational medication in patient with rheumatoid arthritis (RA) who were previously unsuccessfully treated with another medication called a tumor necrosis factor-alpha (TNF-a) inhibitor.
You may be able to participate in the flex-V Study if you:
- are 18 years of age or older
- have been diagnosed with RA for at least 6 months
- have symptoms of active RA such as painful, swollen, and tender joints
- were previously treated with at least one TNF-a inhibitor
- are currently receiving treatment with a disease-modifying antirheumatic drug (DMARD) for at least 8 weeks (12 weeks if you are taking methotrexate).
If you are unsure which medication you are taking, please check with your doctor.
The Flex-V Study will last for up to 76 weeks. You will continue to take your DMARD therapy as usual throughout the study. The study will require regular visits to the study center so that the study doctors and nurses can monitor your RA symptoms and general health.
Taking part in the Flex-V Study will provide new information that will add to the current knowledge about RA treatment, which may potentially help other patients in the future.
For more information, or if you are interested in taking part in the Flex-V Study, please contact: Linda Weber, RN, at the Research Department, Bone and Joint Hospital at St. Anthony, at 405-979-7855, or
Bone and Joint Hospital at St. Anthony
1111 N. Dewey Avenue
Oklahoma City, OK 73103
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these